Clinical Trials Browser

ocaratuzumab × Clear all

NCT00354926 2016-01-07

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Phase 1 Completed

67 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT01858181 2014-03-03

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Phase 1 Unknown

9 enrolled

Lymphoid

Previously Treated CD20+ B-cell Malignancies

NCT00003874 2011-11-29

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating